Concepedia

Mark J. DiNubile

MJ

Statistics

Publications

125

Citations

16.3K

H-Index

52

Active since

1976

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Cooper University Hospital

University of Pennsylvania

Emory University

Mark J. DiNubile is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in infectious diseases, pharmacotherapy, and medicine.

Publications per year

1976–2023

125

Publications

125

Boceprevir for Untreated Chronic HCV Genotype 1 Infection

Fred Poordad, Jonathan McCone, Bruce R. Bacon et al. · New England Journal of Medicine · 2011 · 2.5K citations · Full text

, , +17

Safety and Efficacy of a Pentavalent Human–Bovine (WC3) Reassortant Rotavirus Vaccine

Timo Vesikari, David O. Matson, Penelope H. Dennehy et al. · New England Journal of Medicine · 2006 · 1.9K citations · Full text

, , +17

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

Francisco M. Marty, Per Ljungman, Roy F. Chemaly et al. · New England Journal of Medicine · 2017 · 1.2K citations · Full text

, , +17

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Roy T. Steigbigel, David A. Cooper, Princy Kumar et al. · New England Journal of Medicine · 2008 · 686 citations · Full text

, , +17

Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases

Thomas J. Walsh, John W. Hiemenz, Nita L. Seibel et al. · Clinical Infectious Diseases · 1998 · 624 citations · Full text

, , +17

1–5 of 125